DAPHNE Scale Validation in Frontotemporal Lobar Degeneration
Açar sözlər
Mücərrəd
Təsvir
Psycho-behavioral disorders assessment is crucial for the diagnosis and follow-up of patients with frontotemporal degeneration (FTD). DAPHNE scientific staff have therefore developed a quantification and follow-up scale specifically dedicated to patients with FTD in current clinical practice. This scale is called DAPHNE to Disinhibition, Apathy, Perseveration, Hyperorality, Negligence and loss of Empathy. This study aims to validate this scale. This validation will include methodological steps required to develop a new clinical tool, by studying internal consistency, loyalty, and concurrent validity in comparison with validated existing tools. Complementarily, sensitivity and specificity will be assessed via a control population including patients with Alzheimer's disease, , progressive supranuclear palsy and bipolar disorder with cognitive disorders.
Tarixlər
| Son Doğrulandı: | 07/31/2017 |
| İlk təqdim: | 08/23/2016 |
| Təxmini qeydiyyat təqdim edildi: | 08/29/2016 |
| İlk Göndərmə: | 09/04/2016 |
| Son Yeniləmə Göndərildi: | 08/15/2017 |
| Son Yeniləmə Göndərildi: | 08/20/2017 |
| Həqiqi Təhsilin Başlama Tarixi: | 01/31/2013 |
| Təxmini İlkin Tamamlanma Tarixi: | 12/30/2013 |
| Təxmini İşin Tamamlanma Tarixi: | 12/30/2015 |
Vəziyyət və ya xəstəlik
Müdaxilə / müalicə
Other: Psycho-behavioural assessment
Faza
Qol Qrupları
| Qol | Müdaxilə / müalicə |
|---|---|
| Fronto-temporal lobar degeneration DAPHNE score building and internal validation through Fronto-temporal lobar degeneration patients. | |
| Control External validation of DAPHNE score among patients with Alzheimer's disease, progressive supranuclear palsy and bipolar disorder with cognitive disorders. |
Uyğunluq Kriteriyaları
| Təhsil üçün uyğun yaşlar | 18 Years Üçün 18 Years |
| Təhsilə Uyğun Cinslər | All |
| Nümunə götürmə metodu | Non-Probability Sample |
| Sağlam Könüllüləri qəbul edir | Bəli |
| Kriteriyalar | Inclusion Criteria: Group 1: 1. Patients with FTD according Neary (1998) and Raskowsky (2011) diagnostic criteria. 2. Mini-Mental State Examination ≥ 18 3. Consent Group 2 Control: 1. Patients with Alzheimer's disease (MacKahn, 2011), patients with supranuclear palsy (Litvan, 1996) and patients with bipolar disorder with cognitive disorders. criteria. 2. Mini-Mental State Examination ≥ 18 3. Consent Exclusion Criteria: - Minor patient |
Nəticə
İlkin nəticə tədbirləri
1. Internal validation of DAPHNE Score [Baseline]
